David Lebowitz Score: 44
Analyst at
Citigroup,
New Street
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+39.0%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
85%
11 W / 2 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
69%
9 W / 4 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
15%
2 W / 11 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
8%
1 W / 12 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
89%
8 W / 1 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
85%
11 W / 2 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Oct 30, 2024 |
Exelixis Inc
EXEL
|
BUY |
$38.00
Est. +32%
|
$28.73 | $49.40 |
Target Met
|
$55.85
+94.4%
|
| Oct 30, 2024 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$81.00
Est. +16%
|
$69.91 | $73.51 |
Miss
|
$58.99
-15.6%
|
| Oct 30, 2024 |
Incyte Corp.
INCY
|
BUY |
$97.00
Est. +32%
|
$73.60 | $94.62 |
Precision Hit (±3%)
|
$116.86
+58.8%
|
| Oct 24, 2024 |
BridgeBio Pharma Inc
BBIO
|
BUY |
$45.00
Est. +86%
|
$24.17 | $57.49 |
Target Met
|
$77.19
+219.4%
|
| Sep 24, 2024 |
Cogent Biosciences Inc
COGT
|
BUY |
$15.00
Est. +41%
|
$10.65 | $13.55 |
Miss
|
$38.69
+263.3%
|
| Sep 18, 2024 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$93.00
Est. +31%
|
$71.14 | $73.51 |
Miss
|
$58.99
-17.1%
|
| Sep 17, 2024 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$207.00
Est. +48%
|
$139.57 | $208.16 |
Bullseye Hit (±1%)
|
$274.50
+96.7%
|
| Sep 16, 2024 |
Exelixis Inc
EXEL
|
BUY |
$31.00
Est. +17%
|
$26.46 | $49.40 |
Target Met
|
$55.85
+111.1%
|
| Sep 13, 2024 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$178.00
Est. +51%
|
$118.00 | $208.16 |
Target Met
|
$274.50
+132.6%
|
| Sep 03, 2024 |
Cogent Biosciences Inc
COGT
|
BUY |
$13.00
Est. +19%
|
$10.95 | $13.50 |
Target Met
|
$38.69
+253.3%
|
| Sep 03, 2024 |
Arrowhead Pharmaceuticals Inc.
ARWR
|
BUY |
$27.00
Est. +18%
|
$22.91 | $27.86 |
Target Met
|
$83.99
+266.6%
|
| Aug 18, 2024 |
Incyte Corp.
INCY
|
BUY |
$92.00
Est. +48%
|
$62.16 | $87.24 |
Miss
|
$116.86
+88.0%
|
| May 20, 2024 |
Exelixis Inc
EXEL
|
BUY |
$31.00
Est. +47%
|
$21.06 | $48.85 |
Target Met
|
$55.85
+165.2%
|
Exelixis Inc
EXEL
Oct 30, 2024
Signal & Target
BUY
$38.00
Start Price
$28.73
Best Price (1Y)
$49.40
Current Price
$55.85
Return
+94.4%
Signal & Target
BUY
$81.00
Start Price
$69.91
Best Price (1Y)
$73.51
Current Price
$58.99
Return
-15.6%
Incyte Corp.
INCY
Oct 30, 2024
Signal & Target
BUY
$97.00
Start Price
$73.60
Best Price (1Y)
$94.62
Current Price
$116.86
Return
+58.8%
BridgeBio Pharma Inc
BBIO
Oct 24, 2024
Signal & Target
BUY
$45.00
Start Price
$24.17
Best Price (1Y)
$57.49
Current Price
$77.19
Return
+219.4%
Cogent Biosciences Inc
COGT
Sep 24, 2024
Signal & Target
BUY
$15.00
Start Price
$10.65
Best Price (1Y)
$13.55
Current Price
$38.69
Return
+263.3%
Signal & Target
BUY
$93.00
Start Price
$71.14
Best Price (1Y)
$73.51
Current Price
$58.99
Return
-17.1%
Ascendis Pharma A/S - ADR
ASND
Sep 17, 2024
Signal & Target
BUY
$207.00
Start Price
$139.57
Best Price (1Y)
$208.16
Current Price
$274.50
Return
+96.7%
Exelixis Inc
EXEL
Sep 16, 2024
Signal & Target
BUY
$31.00
Start Price
$26.46
Best Price (1Y)
$49.40
Current Price
$55.85
Return
+111.1%
Ascendis Pharma A/S - ADR
ASND
Sep 13, 2024
Signal & Target
BUY
$178.00
Start Price
$118.00
Best Price (1Y)
$208.16
Current Price
$274.50
Return
+132.6%
Cogent Biosciences Inc
COGT
Sep 03, 2024
Signal & Target
BUY
$13.00
Start Price
$10.95
Best Price (1Y)
$13.50
Current Price
$38.69
Return
+253.3%
Arrowhead Pharmaceuticals Inc.
ARWR
Sep 03, 2024
Signal & Target
BUY
$27.00
Start Price
$22.91
Best Price (1Y)
$27.86
Current Price
$83.99
Return
+266.6%
Incyte Corp.
INCY
Aug 18, 2024
Signal & Target
BUY
$92.00
Start Price
$62.16
Best Price (1Y)
$87.24
Current Price
$116.86
Return
+88.0%
Exelixis Inc
EXEL
May 20, 2024
Signal & Target
BUY
$31.00
Start Price
$21.06
Best Price (1Y)
$48.85
Current Price
$55.85
Return
+165.2%